AML Mutation Analysis Only : 1016109

Test Code

MDFCPAMLSEQ or 1016109

Alias/See Also

Acute Myeloid Leukemia; AML; Acute Promyelocytic Leukemia; APL; AML; ASXL1; c-kit; DNMT3A; ETV6 (TEL); FLT3; IDH1; IDH2; KRAS; NPM1; NRAS; PHF6; PTEN; RUNX1; SF3B1; SRSF2; TET2; TP53; U2AF1; WT1; CEBPA; FLT3-ITD-TKD

CPT Codes
81450

Includes

Includes: ASXL1, CEBPA, DNMT3A, ETV6 (TEL), FLT3, FLT3-ITD, IDH1, IDH2, KIT, KRAS, NPM1, NRAS, PHF6, PTEN, RUNX1, SF3B1, SRSF2, TET2, TP53, U2AF1, WT1

Instructions

Peripheral Blood or Bone Marrow in a lavender top (EDTA) tube.

Transport Container

Submit 5-10 mL Blood or 2-3 mL Bone Marrow. Do not centrifuge.

Transport Temperature

Refrigerated.

Specimen Stability

Ambient: 48 hours; Refrigerated: 15 days; Frozen: Unacceptable

Methodology
Next Generation Sequencing, PCR and Fragment Analysis, and for CEBPA only Next Generation Sequencing at Quest Diagnostics San Juan Capistrano Laboratory

Setup Schedule

Monday & Thursday

Report Available

10-14 days

Reference Range

An integrated report with results from all tests along with relevant diagnostic, prognostic and clinical trial information.

Clinical Significance

Helps physicians diagnose and predict the course of disease progression for hematologic diseases.

Performing Laboratory
med fusion; CEBPA Quest SJC

The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.